Sanofi SA has a consensus price target of $28.75, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, Argus Research, and Deutsche Bank on January 23, 2024, March 27, 2023, and August 12, 2022. With an average price target of $38.33 between Morgan Stanley, Argus Research, and Deutsche Bank, there's an implied -19.74% downside for Sanofi SA from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/23/2024 | SNY | Buy Now | Sanofi | $47.76 | 15.16% | Morgan Stanley | Mark Purcell | → $55 | Initiates | → Equal-Weight | Get Alert |
03/27/2023 | SNY | Buy Now | Sanofi | $47.76 | 25.63% | Argus Research | Jasper Hellweg | $55 → $60 | Maintains | Buy | Get Alert |
08/12/2022 | SNY | Buy Now | Sanofi | $47.76 | — | Deutsche Bank | Emmanuel Papadakis | — | Upgrade | Sell → Hold | Get Alert |
09/27/2021 | SNY | Buy Now | Sanofi | $47.76 | — | SVB Leerink | Geoffrey Porges | — | Upgrade | Market Perform → Outperform | Get Alert |
The latest price target for Sanofi (NASDAQ: SNY) was reported by Morgan Stanley on January 23, 2024. The analyst firm set a price target for $55.00 expecting SNY to rise to within 12 months (a possible 16.92% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for Sanofi (NASDAQ: SNY) was provided by Morgan Stanley, and Sanofi initiated their equal-weight rating.
The last upgrade for Sanofi SA happened on August 12, 2022 when Deutsche Bank raised their price target to N/A. Deutsche Bank previously had a sell for Sanofi SA.
There is no last downgrade for Sanofi.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sanofi, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sanofi was filed on January 23, 2024 so you should expect the next rating to be made available sometime around January 23, 2025.
While ratings are subjective and will change, the latest Sanofi (SNY) rating was a initiated with a price target of $0.00 to $55.00. The current price Sanofi (SNY) is trading at is $47.04, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.